BridgeBio Pharma, Inc. 10-K filing
Filed 2026-02-24 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001743881-26-000009
- Form type
- 10-K
- CIK
- 0001743881
- Primary document
- https://www.sec.gov/Archives/edgar/data/1743881/000174388126000009/bbio-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BridgeBio Pharma, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $502.1M | - | - |
| Cost Of Revenue | $21.0M | - | - |
| Operating Income | $-523.4M | - | - |
| Eps Basic | -3.78 | - | - |
| Eps Diluted | -3.78 | - | - |
| Cash And Equivalents | $570.1M | - | - |
| Total Assets | $936.0M | - | - |
| Total Liabilities | $3.0B | - | - |
| Shareholders Equity | $-2.1B | - | - |
| Operating Cash Flow | $-445.9M | - | - |
| Capital Expenditures | $1.1M | - | - |